We are live on ! Find out more
SGTX

Sigilon Therapeutics, Inc. Common Stock
SGTX

Delisted

SGTX was delisted on the 10th of August, 2023.

Back to rankings

1 hedge funds and large institutions have $4.49K invested in Sigilon Therapeutics, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% less funds holding

Funds holding: 16 → 1 (-15)

94% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 16

100% less capital invested

Capital invested by funds: $26.6M → $4.49K (-$26.6M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
1
Holders Change
-15
Holders Change %
-93.75%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IA
IFP Advisors
Florida
+$4.33K

Top Sellers

Rank Fund Capital Flow
1
FP
Flagship Pioneering
Massachusetts
-$18M
2
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board
Ontario, Canada
-$2.57M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.77M
4
HP
Harbourvest Partners
Massachusetts
-$1.28M
5
YCM
Yakira Capital Management
Connecticut
-$895K
Name Holding Trade Value Shares
Change 		Change in
Stake
IA
1
IFP Advisors
Florida
$4.49K +$4.33K +200 New
FP
2
Flagship Pioneering
Massachusetts
– -$18M -797,720 Closed
Canada Pension Plan Investment Board
3
Canada Pension Plan Investment Board
Ontario, Canada
– -$2.57M -114,244 Closed
Fidelity Investments
4
Fidelity Investments
Massachusetts
– -$1.77M -78,796 Closed
HP
5
Harbourvest Partners
Massachusetts
– -$1.28M -56,979 Closed
YCM
6
Yakira Capital Management
Connecticut
– -$895K -39,746 Closed
State of Wisconsin Investment Board
7
State of Wisconsin Investment Board
Wisconsin
– -$882K -39,202 Closed
Vanguard Group
8
Vanguard Group
Pennsylvania
– -$521K -23,144 Closed
CL
9
CSS LLC
Illinois
– -$299K -13,292 Closed
BCM
10
Bridgeway Capital Management
Texas
– -$216K -9,615 Closed
Morgan Stanley
11
Morgan Stanley
New York
– -$144K -6,418 Closed
TRCT
12
Tower Research Capital (TRC)
New York
– -$46.6K -2,069 Closed
BlackRock
13
BlackRock
New York
– -$5.7K -253 Closed
Royal Bank of Canada
14
Royal Bank of Canada
Ontario, Canada
– -$3K -131 Closed
Wells Fargo
15
Wells Fargo
California
– -$180 -8 Closed
Osaic Holdings
16
Osaic Holdings
Arizona
– -$157 -7 Closed
Bank of America
17
Bank of America
North Carolina
– -$23 -1 Closed

SGTX Hedge Fund Activity: Q3 2023 in Review

1 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Sigilon Therapeutics, Inc. Common Stock (SGTX) for Q3 2023, worth a combined $4.49K — down 100% from $26.6M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of SGTX and 1 opened new positions — a net loss of 15 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was IFP Advisors, opening a new position worth an estimated $4.33K. The largest seller was Flagship Pioneering, exiting entirely with an estimated $18M sold.

  • 1 institutional investor held Sigilon Therapeutics, Inc. Common Stock (SGTX) as of Q3 2023, down from 16 in Q2 2023.
  • Funds reported $4.49K of Sigilon Therapeutics, Inc. Common Stock stock for Q3 2023, down 100% quarter-over-quarter.
  • 1 fund opened new Sigilon Therapeutics, Inc. Common Stock positions in Q3 2023 and 16 closed out, a net change of -15 holders.
  • The largest Sigilon Therapeutics, Inc. Common Stock buyer in Q3 2023 was IFP Advisors, an estimated $4.33K added.
  • The largest Sigilon Therapeutics, Inc. Common Stock seller in Q3 2023 was Flagship Pioneering, an estimated $18M sold.

Based on aggregated 13F filings for Q3 2023.